These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21177715)

  • 1. 'I put it on the back burner most days': Living with chronic risk.
    Etchegary H
    Health (London); 2011 Nov; 15(6):633-49. PubMed ID: 21177715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychosocial consequences of presymptomatic genetic testing. A retrospective study of testing for Huntington disease].
    Jakobsen LB; Malt U; Nilsson B; Rosenlund S; Heiberg A
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1913-6. PubMed ID: 10382341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington's disease.
    Schwartz RR
    J Neurosci Nurs; 2010 Jun; 42(3):157-68. PubMed ID: 20550076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early testing for Huntington disease in children: pros and cons.
    Toufexis M; Gieron-Korthals M
    J Child Neurol; 2010 Apr; 25(4):482-4. PubMed ID: 19808987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare experiences of families affected by Huntington disease: need for improved care.
    Etchegary H
    Chronic Illn; 2011 Sep; 7(3):225-38. PubMed ID: 21602250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
    Bloch M; Adam S; Wiggins S; Huggins M; Hayden MR
    Am J Med Genet; 1992 Feb; 42(4):499-507. PubMed ID: 1535177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term impact of Huntington disease linkage testing.
    Taylor CA; Myers RH
    Am J Med Genet; 1997 Jun; 70(4):365-70. PubMed ID: 9182776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Philippe K; Demyttenaere K; Dom R; Vandenberghe W; Fryns JP
    Eur J Hum Genet; 2007 Apr; 15(4):453-62. PubMed ID: 17245406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive testing for Huntington's disease.
    Tibben A
    Brain Res Bull; 2007 Apr; 72(2-3):165-71. PubMed ID: 17352941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Theory of Genetic Vulnerability: a Roy model exemplar.
    Hamilton RJ; Bowers BJ
    Nurs Sci Q; 2007 Jul; 20(3):254-64. PubMed ID: 17595406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of living with a strong family history of breast cancer.
    Maheu C
    Can J Nurs Res; 2009 Jun; 41(2):100-12. PubMed ID: 19650516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption and the communication of genetic risk: experiences in Huntington disease.
    Bombard Y; Semaka A; Hayden MR
    Clin Genet; 2012 Jan; 81(1):64-9. PubMed ID: 21204796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dilemmas of anonymous predictive testing for Huntington disease: privacy vs. optimal care.
    Burgess MM; Adam S; Bloch M; Hayden MR
    Am J Med Genet; 1997 Aug; 71(2):197-201. PubMed ID: 9217222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation.
    Bombard Y; Penziner E; Decolongon J; Klimek ML; Creighton S; Suchowersky O; Guttman M; Paulsen JS; Bottorff JL; Hayden MR
    Clin Genet; 2007 Mar; 71(3):220-31. PubMed ID: 17309644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living with Huntington's disease: need for supportive care.
    Dawson S; Kristjanson LJ; Toye CM; Flett P
    Nurs Health Sci; 2004 Jun; 6(2):123-30. PubMed ID: 15130098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing.
    d'Agincourt-Canning L
    Clin Genet; 2006 Dec; 70(6):462-72. PubMed ID: 17100990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Predictive diagnostics in chorea huntington: psychotherapeutic implications for counselling].
    Richartz-Salzburger E; Mau-Holzmann U; Schott KJ; Buchkremer G
    Psychiatr Prax; 2006 Jul; 33(5):211-7. PubMed ID: 16802259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological impact of news of genetic risk for Huntington disease.
    Horowitz MJ; Field NP; Zanko A; Donnelly EF; Epstein C; Longo F
    Am J Med Genet; 2001 Oct; 103(3):188-92. PubMed ID: 11745989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
    Metcalfe A; Werrett J; Burgess L; Clifford C
    Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.